Recent regulatory guidance documents, such as the 2025 Australian Therapeutic Goods Administration (TGA) guidance on the quality of listed probiotic medicines and broader discussions on LBPs from 2020, underscore the necessity for strain-level identification, validated enumeration techniques, and explicit labeling of potency and storage conditions (570, 571)
Civil Engineering, UCLA Last updated: June 2026 Human-researched and AI-assisted with full editorial review
doi: 10.3390/toxins13070452 Jiang, Yan, Castro, Joel, Blomster, Linda V., Agwa, Akello J., Maddern, Jessica, Schober, Gudrun, Herzig, Volker, Chow, Chun Yuen, Cardoso, Fernanda C., Demtrio De Souza Frana, Paula, Gonzales, Junior, Schroeder, Christina I., Esche, Steffen, Reiner, Thomas, Brierley, Stuart M
Last June at a conference, I was struck by a comment from one of the speakers who talked about the importance of getting away from the current National Sickness Service back to the true ideal of a National Health Service treating patients holistically, focusing on prevention and not just cure, and long-term joint responsibility with the patient for wellness and well-being
Sen SK, Pukazhvanthen P, Armstrong R
